We are live on
!
Find out more
PPBT
Purple Biotech
PPBT
PPBT
1 hedge funds and large institutions have $6K invested in Purple Biotech in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.27K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $6K | +$6.27K | +1 | New |
|
PPBT Hedge Fund Activity: Q4 2015 in Review
1 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q4 2015, worth a combined $6K.
Buyers outnumbered sellers: 1 fund opened new PPBT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $6.27K.
- 1 institutional investor held Purple Biotech (PPBT) as of Q4 2015, up from 0 in Q3 2015.
- Funds reported $6K of Purple Biotech stock for Q4 2015.
- 1 fund opened new Purple Biotech positions in Q4 2015 and 0 closed out, a net change of +1 holder.
- The largest Purple Biotech buyer in Q4 2015 was UBS Group, an estimated $6.27K added.
Based on aggregated 13F filings for Q4 2015.